You can only gain access to certain items and special pricing if you have logged in. Login Now.
FACT Quality Immune Effector Cellular Therapy for the Treatment of Solid Tumors: General Concepts and Need for Harmonization of Standards
Format:
Electronic (digital download/no shipping)
Accredited Organization, Guest, NonMember -
$100.00
Industry -
$500.00
Inspector, Inspector Trainee -
$0.00
Description:
This webinar offers an introduction to Immune Effector Cellular (IEC) Therapy for the treatment of solid tumors. Basem William, MD, MRCP, FACP from the OhioHealth Blood and Marrow Transplant and Cellular Therapy Program and Sarah Nikiforow, MD, PhD from the Dana-Farber Cancer Institute Cell Manipulation Core Facility in Boston discussed unique challenges and considerations in IEC manufacturing; listed subtypes of IECs in solid tumors including TILs, CAR-T cells, and TCRs, and examined the need for quality standards.
Product Details:
| Product ID: | 475 |
|---|---|
| Publication Year: | 2022 |
| Pages, Size, or Length: | 90 minutes |
